you are here:

Syncom Healthcare Ltd.

BSE: 533157 | NSE: SYNCOM | Series: NA | ISIN: INE602K01014 | SECTOR: Pharmaceuticals

BSE Live

Jun 28, 16:00
4.06 0.00 (0.00%)
Volume
AVERAGE VOLUME
5-Day
256,245
10-Day
153,245
30-Day
193,756
163,615
  • Prev. Close

    4.06

  • Open Price

    3.95

  • Bid Price (Qty.)

    4.07 (491)

  • Offer Price (Qty.)

    4.33 (361)

Syncom Healthcare is not traded on BSE in the last 30 days

NSE Live

Jun 28, 15:57
4.20 0.00 (0.00%)
Volume
AVERAGE VOLUME
5-Day
281,668
10-Day
191,676
30-Day
157,280
332,739
  • Prev. Close

    4.20

  • Open Price

    4.10

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    4.20 (50)

Syncom Healthcare is not traded on NSE in the last 30 days

Annual Report

For Year :
2013

Chairman's Speech

Dear Shareholders, With immense pleasure and great satisfaction I take the privilege to present this 11th Annual Report of SYNCOM Healthcare Limited. These 11 years are like milestones this Company achieved with a vision for excellence in the field of product quality, customer service & innovating newer formulations. I feel happy to state that your company has substantially accelerated the speed of its export operations in last two years and spread its wings to cover the major countries of Asian and African continent. After achieving the much prestigious WHO GMP certification, Syncom has listed itself among the top upcoming companies, who by their earnest efforts have successfully catered their products not only to domestic market but also marked their presence in international market. This success has come to us with a strong and dedicated team of over 400 trained and well qualified marketing professionals, 70 distributors, 2500 stockists and more than 5 lacs retailers nationwide. The success of last 11 years has been a source of inspiration for Syncom to keep itself tuned to the latest developments taking place in healthcare industry, along with updating its strengths of human resource, market research, finance management and innovating unique * formulations to maintain its commitment of high profitability to its valued investors. My sincere thanks to all the shareholders of Syncom for showing their confidence in this company. I assure you of our best efforts to keep up your expectations always. Sincerely yours Date: 14th August, 2013 Ajay S. Bankda Chairman